返回 Agenda
Session 6 LOOKING AT THE FUTURE
Session Chair(s)
Mark Turner, MD, PhD, MRCP, FFPM
Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology
University of Liverpool, United Kingdom
This session will be the opportunity to look at the future and discuss how to overcome the remaining challenges and optimise opportunities to deliver innovative and efficient drugs that address children’s needs. All stakeholders have key roles and responsibilities in bringing new and beneficial medicines to Children in Europe. They face different challenges that are unique to Europe, while medicines are developed for global purpose. This panel discussion aims to promote common understanding and alignment on some important points from different stakeholders and will set the scene for future dialogue.
Speaker(s)
Edmund Jessop, DrMed
National Health Service, United Kingdom
Medical adviser at NHS England
Looking at the future
Gilles Vassal, MD, PhD
Institute Gustave Roussy, France
Head of Clinical Research Division
Dimitrios Athanasiou, MBA
WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS, Greece
Patient Advocate
Looking at the Future
Vinciane Pirard, MD
Sanofi-Genzyme, Belgium
Senior Director Public Affairs (Europe & International)
Looking at the Future
Siri Wang
Norwegian Medical Products Agency, Norway
Scientific Director; PDCO delegate
Looking at the Future
Ralph Bax, MD, PhD
European Medicines Agency, Netherlands
Head of the Paediatric Medicines Office